These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 872142

  • 1. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR, Atkins LM, Meischen SJ, Smith AB, Walker EM.
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [Abstract] [Full Text] [Related]

  • 2. Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
    Gale GR, Atkins LM, Meischen SJ, Schwartz P.
    Cancer Treat Rep; 1979 Mar; 63(3):449-56. PubMed ID: 427825
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR, Atkins LM, Meischen SJ, Smith AB, Walker EM.
    J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
    [Abstract] [Full Text] [Related]

  • 4. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM, Gale GR.
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
    Burchenal JH, O'Toole T, Kalaher K, Chisholm J.
    Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
    [Abstract] [Full Text] [Related]

  • 6. Synergistic action of high-dose hydroxyurea when used with cyclophosphamide and certain new organoplatinum complexes in treatment of advanced L1210 leukemia.
    Gale GR, Atkins LM, Meischen SJ, Schwartz P.
    Cancer; 1978 Apr; 41(4):1230-4. PubMed ID: 638988
    [Abstract] [Full Text] [Related]

  • 7. Single versus combination chemotherapy of L1210 leukemia.
    Koza I, Balázová E, Ujházy V.
    Neoplasma; 1980 Apr; 27(6):691-6. PubMed ID: 7254424
    [Abstract] [Full Text] [Related]

  • 8. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM, Helfman D.
    Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
    [Abstract] [Full Text] [Related]

  • 9. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL, Roberts D.
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [Abstract] [Full Text] [Related]

  • 10. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN, Milushev AS, Todorov DK.
    Neoplasma; 1980 Mar; 27(1):33-6. PubMed ID: 6892839
    [Abstract] [Full Text] [Related]

  • 11. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D, Hilliard SL.
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP, Cros S, Armand JP.
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV.
    Cancer Res; 1988 Apr 01; 48(7):1745-52. PubMed ID: 3162402
    [Abstract] [Full Text] [Related]

  • 15. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP, Trader MW, Frei E, Peters WP, Wolpert MK, Laster WR.
    Cancer Res; 1987 May 01; 47(9):2323-7. PubMed ID: 3567926
    [Abstract] [Full Text] [Related]

  • 16. Antileukemic properties of organoplatinum complexes.
    Meischen SJ, Gale GR, Lake LM, Frangakis CJ, Rosenblum MG, Walker EM, Atkins LM, Smith AB.
    J Natl Cancer Inst; 1976 Oct 01; 57(4):841-5. PubMed ID: 1003531
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Oct 01; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 19. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST, Bleyer WA.
    Cancer Res; 1974 Aug 15; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN, Miloushev AS.
    Biomedicine; 1980 Apr 15; 33(2):42-4. PubMed ID: 6447522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.